Phase Forward's Empirica Suite to be showcased at the 3rd annual conference

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will participate in the 3rd annual World Drug Safety Congress Europe, to be held September 15-18 at the Bloomsbury Hotel in London, U.K.

On Wednesday, September 16, from 1:30-2:00 p.m. local time, Robert Weber, principal consultant of Phase Forward’s Lincoln Safety Group, will participate in stream session 2 titled “Post Marketing Safety Strategy.” Mr. Weber’s presentation will review the prioritization, tracking and management of signals from multiple sources, such as spontaneous adverse event reports, clinical studies and observational studies. In addition, Mr. Weber will discuss the importance of processes and integrated tools to deliver improved safety monitoring and risk management.

Phase Forward will also showcase its safety solutions, the Empirica™ Suite, which comprises the following products: Empirica Trace, Empirica Gateway, Empirica Signal and Empirica Study.

http://www.phaseforward.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.